Evidence map›Paper›PMID 29535739›Full record

ArticleFrontiers in immunology2018

Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation.

James L Quinn, Gaurav Kumar, Agnieshka Agasing, Rose M Ko, Robert C Axtell

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Myelin-reactive B cells exacerbate CD4Nature communications · 2024
    Article
  9. Article
  10. Review
  11. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  12. Review
  13. Article
  14. Review
  15. Synapse Dysfunctions in Multiple Sclerosis.International journal of molecular sciences · 2023
    Review
  16. Review
  17. Article
  18. The immunology of multiple sclerosis.Nature reviews. Immunology · 2022
    Review
  19. Review
  20. Clickable Biomaterials for Modulating Neuroinflammation.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

James L QuinnDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Gaurav KumarArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Agnieshka AgasingDepartment of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States.
Rose M KoArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Robert C AxtellArthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, United States.
Oklahoma Medical Research Foundation · USUniversity of Oklahoma Health Sciences Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI TIMOTHY M VANWAGONER · 2013 to 2026
$68.2M
Molecular Basis of Immunity - Kirschtein-NRSAT32AI007633 · NIAID · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CUNNINGHAM, MADELEINE W. · 2001 to 2022
$4.0M
Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases.R01AI137047 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AXTELL, ROBERT C · 2018 to 2021
$2.8M
Pathogenic B cell and T helper cell interactions in Neuromyelitis OpticaR01EY027346 · NEI · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AXTELL, ROBERT C · 2017 to 2021
$2.2M
Functional Interaction Between T-cell and B-cell Immune Pathways in Neuro- inflammatory DisordersR56AI118787 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI AXTELL, ROBERT C, LESSARD, CHRISTOPHER J · 2016 to 2016
$646k
NEI NIH HHS R01 EY027346NIAID NIH HHS R01 AI137047NIAID NIH HHS R56 AI118787NIAID NIH HHS T32 AI007633NIGMS NIH HHS U54 GM104938
6 · The paper itself

Abstract

Both T cells and B cells are implicated in the pathology of multiple sclerosis (MS), but how these cells cooperate to drive disease remains unclear. Recent studies using experimental autoimmune encephalomyelitis (EAE) demonstrated that the TH17 pathway is correlated with increased numbers of ectopic B-cell follicles in the central nervous system (CNS). As follicular T helper (TFH) cells are regulators of B cell responses, we sought to examine the role of TFH cells in EAE induced by the transfer of myelin-specific TH17 cells (TH17-EAE). In this study, we first confirmed previous reports that B-cells are a major cell type infiltrating the CNS during TH17-EAE. In addition, we found that B cells contribute to the severity of TH17-EAE. Class-switched B-cells in the CNS were positively correlated with disease and, strikingly, the severity TH17-EAE was diminished in B cell deficient mice. We next focused on the role TFH cells play in TH17-EAE. We found substantial numbers of CXCR5

Indexed as

AnimalsAntibodies, BlockingB-LymphocytesCell MovementCells, CulturedCentral Nervous SystemChemokine CXCL13ChoristomaDisease Models, AnimalEncephalomyelitis, Autoimmune, ExperimentalGerminal CenterHumansInterleukin-17MiceMice, Inbred C57BLMultiple SclerosisAntibodies, BlockingChemokine CXCL13Interleukin-17B cellsCXCL13experimental autoimmune encephalomyelitismultiple sclerosisTFHTh17

Identifiers

PMID29535739
PMCPMC5835081
OpenAlexW2789943585

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.